openPR Logo
Press release

Sustained Release Excipients Market: Growth Dynamics| by key vendors FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company

06-17-2019 03:02 PM CET | Health & Medicine

Press release from: Future Market Insights

Sustained Release Excipients Market: Growth Dynamics| by key

Future Market Insights offers an exhaustive evaluation of the sustained release excipients landscape in a new research outlook

A recently released global market intelligence outlook on sustained release excipients forecasts the revenue through sustained release excipients to surpass a million dollar value by this year’s end, of which just-under 1/3rd share belongs to North America.

As a growing number of existing international patents are expiring and the prevalence of orthopedic disorders is increasing on the flipside, drug formulations and thereby sustained release excipients are constantly witnessing an impressive manufacturing outlook.

Research identifies the largest revenue shareholding categories in sustained release excipients marketplace on the basis of product type, end user, and route of administration.

Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7580

Polymer is currently the largest product type category worth US$ 300 Mn, whereas gelatin represents the most opportunistic one.

While oral route of administration remains highly sought after, injectable is presumed to gradually take over.

Biopharmaceutical companies and CMOs pose fierce competition to pharmaceutical companies - the dominant end user of sustained release excipients.

Click here (Preview) for an insightful view of sustained release excipients marketplace.

“The top five players leading the competition in global sustained release excipients landscape account for a collective revenue share of over 50%, whereas a number of relatively small companies represent the rest. A majority of competitors have a limited offering portfolio and significantly depend on product differentiation for an edge in niche treatment areas,” explains a senior research analyst. “Product innovation and market expansion have been the top developmental strategies of companies so far, which are now complemented with strategic partnerships,” the analyst adds further.

Multi-level Partnerships – The Key to Delivering Top Notch Excipient Formulations

FMI underlines the critical role of strategic collaborations - between formulators of sustained release excipients and stakeholders across the value chain – in shaping growth of brands as well as the entire sustained release excipients ecosystem.

Download Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-7580

While partnerships are expected to prominently focus on spotting the key challenges facing manufacturers, continued education about functionality, variability, and consistency of sustained release excipients is also be an important objective. Drug product manufacturers working in tandem with formulators of sustained release excipients is helping companies deliver best-in-class solutions addressing the most prominent pull factors associated with sustained release excipients.

To best grasp real-time market needs, sustained release excipient formulators are most likely to strengthen interaction with end-use customers. This move offers a dual advantage as a developmental strategy – by helping manufacturers precisely understand and address the challenges facing pharmaceutical markets and stimulating development of new excipient formulations that tap into evolving needs.

A recent deal (2017) involving the combination of The Dow Chemical Company-DuPont-FMC (Health & Nutrition) has been a classic example of collaborative operation, involving channel partners as well as customers.

Sustained Release Excipients Market Reports - Table of Contents

1. Executive Summary
2. Market Introduction
3. Sustained Release Excipients Market Opportunity Analysis
4. Sustained Release Excipients Market Analysis Scenario
5. Global Economic Outlook
6. North America Sustained Release Excipients Market Analysis and Forecast
7. Latin America Sustained Release Excipients Market Analysis and Forecast
8. Europe Sustained Release Excipients Market Analysis and Forecast
9. CIS & Russia Sustained Release Excipients Market Analysis and Forecast
10. Asia Pacific Sustained Release Excipients Market Analysis and Forecast

Buy Full Report Now @ https://www.futuremarketinsights.com/checkout/7580

Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Website: https:www.futuremarketinsights.com

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sustained Release Excipients Market: Growth Dynamics| by key vendors FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company here

News-ID: 1777936 • Views:

More Releases from Future Market Insights

Global Pectin Market Poised for Steady Growth as Innovation, Sustainability, and Consumer Shifts Drive Expansion
Global Pectin Market Poised for Steady Growth as Innovation, Sustainability, and …
The global pectin market is entering a dynamic growth phase, with its valuation projected to rise from USD 1,125.9 million in 2025 to USD 2,074.2 million by 2035, advancing at a CAGR of 6.3%. Unlike many markets driven by broad consumer preferences, the pectin industry's trajectory is fueled by technological advancements, targeted product development, and a rising demand for sustainable and natural solutions. Both established manufacturers and emerging players are
Isomalto-oligosaccharide Market Poised for Growth as Health-Conscious Consumers Drive Demand
Isomalto-oligosaccharide Market Poised for Growth as Health-Conscious Consumers …
The global Isomalto-oligosaccharide (IMO) market is entering a period of strong growth, fueled by changing dietary preferences, rising health awareness, and a surge in innovation among manufacturers. Valued at USD 86.8 million in 2025, the market is projected to nearly double, reaching USD 181.6 million by 2035 at a steady CAGR of 7.7%. The momentum reflects a growing consumer shift toward healthier lifestyles, particularly as awareness around obesity, diabetes, and gut
Ashwagandha Extract Market Set for Strong Growth, Driven by Health Awareness, Scientific Validation, and Expanding Manufacturer Participation
Ashwagandha Extract Market Set for Strong Growth, Driven by Health Awareness, Sc …
The global Ashwagandha Extract market is on a dynamic growth path, projected to rise from USD 815.7 million in 2025 to USD 1,787.2 million by 2035, achieving a CAGR of 8.2% over the forecast period. This momentum reflects a powerful convergence of consumer health awareness, scientific validation of Ashwagandha's benefits, and manufacturers-both established leaders and emerging players-introducing innovative formulations to capture growing demand. The surge in demand comes at a time
Taurine Market to Reach USD 954.8 Million by 2035, Backed by Expanding Use in Health, Nutrition, and Pet Care
Taurine Market to Reach USD 954.8 Million by 2035, Backed by Expanding Use in He …
The global taurine market is on track for robust growth over the next decade, with demand rising from USD 476.4 million in 2025 to USD 954.8 million by 2035, representing a healthy CAGR of 7.2%. This expansion is fueled by taurine's growing role across health supplements, infant nutrition, functional foods, energy beverages, and pet health products. Taurine, an amino acid long recognized for its cardiovascular, metabolic, and neurological benefits, is increasingly

All 5 Releases


More Releases for Excipient

Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Albumin Excipient Market Size Growth Forecast: What to Expect by 2025? The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197 Market Analysis: Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027. The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and